阳性HBsAg急性肝炎伴有连接门静脉到中央 静脉的桥形坏死患者,大部分都可发展为慢性活动性肝炎与肝硬化。其实,桥形坏死可逐渐被血管纤维膜代替,出现门脉周围性肝炎。免疫抑制药物是否可以防止该病向慢性化进展,仍是一个未解决的问题。至今,类固醇已被使用,但就随机对照研究的结果来看,这种治疗对病程是有害的。而阳性 Positive HBsAg Acute hepatitis with bridge-shaped necrosis of the portal vein to the central vein, most of which can develop chronic active hepatitis and cirrhosis. In fact, bridge necrosis can be gradually replaced by vascular fiber membrane, there peripheral portal hypertension. Whether immunosuppressive drugs can prevent the disease from progressing to chronicity remains an open problem. To date, steroids have been used, but on the results of randomized controlled studies, this treatment is detrimental to the course of the disease. And positive